500 related articles for article (PubMed ID: 23722903)
1. Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus.
Knight JS; Zhao W; Luo W; Subramanian V; O'Dell AA; Yalavarthi S; Hodgin JB; Eitzman DT; Thompson PR; Kaplan MJ
J Clin Invest; 2013 Jul; 123(7):2981-93. PubMed ID: 23722903
[TBL] [Abstract][Full Text] [Related]
2. Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice.
Knight JS; Subramanian V; O'Dell AA; Yalavarthi S; Zhao W; Smith CK; Hodgin JB; Thompson PR; Kaplan MJ
Ann Rheum Dis; 2015 Dec; 74(12):2199-206. PubMed ID: 25104775
[TBL] [Abstract][Full Text] [Related]
3. Peptidylarginine deiminase inhibition reduces vascular damage and modulates innate immune responses in murine models of atherosclerosis.
Knight JS; Luo W; O'Dell AA; Yalavarthi S; Zhao W; Subramanian V; Guo C; Grenn RC; Thompson PR; Eitzman DT; Kaplan MJ
Circ Res; 2014 Mar; 114(6):947-56. PubMed ID: 24425713
[TBL] [Abstract][Full Text] [Related]
4. At the Bedside: Neutrophil extracellular traps (NETs) as targets for biomarkers and therapies in autoimmune diseases.
Barnado A; Crofford LJ; Oates JC
J Leukoc Biol; 2016 Feb; 99(2):265-78. PubMed ID: 26658004
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of PAD4-mediated NET formation by cl-amidine prevents diabetes development in nonobese diabetic mice.
Shen Y; You Q; Wu Y; Wu J
Eur J Pharmacol; 2022 Feb; 916():174623. PubMed ID: 34767782
[TBL] [Abstract][Full Text] [Related]
6. Peptidylarginine deiminases 2 and 4 modulate innate and adaptive immune responses in TLR-7-dependent lupus.
Liu Y; Lightfoot YL; Seto N; Carmona-Rivera C; Moore E; Goel R; O'Neil L; Mistry P; Hoffmann V; Mondal S; Premnath PN; Gribbons K; Dell'Orso S; Jiang K; Thompson PR; Sun HW; Coonrod SA; Kaplan MJ
JCI Insight; 2018 Dec; 3(23):. PubMed ID: 30518690
[TBL] [Abstract][Full Text] [Related]
7. Suppression of colitis in mice by Cl-amidine: a novel peptidylarginine deiminase inhibitor.
Chumanevich AA; Causey CP; Knuckley BA; Jones JE; Poudyal D; Chumanevich AP; Davis T; Matesic LE; Thompson PR; Hofseth LJ
Am J Physiol Gastrointest Liver Physiol; 2011 Jun; 300(6):G929-38. PubMed ID: 21415415
[TBL] [Abstract][Full Text] [Related]
8. N-α-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis.
Willis VC; Gizinski AM; Banda NK; Causey CP; Knuckley B; Cordova KN; Luo Y; Levitt B; Glogowska M; Chandra P; Kulik L; Robinson WH; Arend WP; Thompson PR; Holers VM
J Immunol; 2011 Apr; 186(7):4396-404. PubMed ID: 21346230
[TBL] [Abstract][Full Text] [Related]
9. Cl-Amidine Prevents Histone 3 Citrullination and Neutrophil Extracellular Trap Formation, and Improves Survival in a Murine Sepsis Model.
Biron BM; Chung CS; O'Brien XM; Chen Y; Reichner JS; Ayala A
J Innate Immun; 2017; 9(1):22-32. PubMed ID: 27622642
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of peptidylarginine deiminase alleviates LPS-induced pulmonary dysfunction and improves survival in a mouse model of lethal endotoxemia.
Liang Y; Pan B; Alam HB; Deng Q; Wang Y; Chen E; Liu B; Tian Y; Williams AM; Duan X; Wang Y; Zhang J; Li Y
Eur J Pharmacol; 2018 Aug; 833():432-440. PubMed ID: 29981294
[TBL] [Abstract][Full Text] [Related]
11. Targeting peptidylarginine deiminase reduces neutrophil extracellular trap formation and tissue injury in severe acute pancreatitis.
Madhi R; Rahman M; Taha D; Mörgelin M; Thorlacius H
J Cell Physiol; 2019 Jul; 234(7):11850-11860. PubMed ID: 30515825
[TBL] [Abstract][Full Text] [Related]
12. Polydatin effectively attenuates disease activity in lupus-prone mouse models by blocking ROS-mediated NET formation.
Liao P; He Y; Yang F; Luo G; Zhuang J; Zhai Z; Zhuang L; Lin Z; Zheng J; Sun E
Arthritis Res Ther; 2018 Nov; 20(1):254. PubMed ID: 30419963
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil extracellular trap-derived enzymes oxidize high-density lipoprotein: an additional proatherogenic mechanism in systemic lupus erythematosus.
Smith CK; Vivekanandan-Giri A; Tang C; Knight JS; Mathew A; Padilla RL; Gillespie BW; Carmona-Rivera C; Liu X; Subramanian V; Hasni S; Thompson PR; Heinecke JW; Saran R; Pennathur S; Kaplan MJ
Arthritis Rheumatol; 2014 Sep; 66(9):2532-2544. PubMed ID: 24838349
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2.
Carmona-Rivera C; Zhao W; Yalavarthi S; Kaplan MJ
Ann Rheum Dis; 2015 Jul; 74(7):1417-24. PubMed ID: 24570026
[TBL] [Abstract][Full Text] [Related]
15. The role of neutrophils in the pathogenesis of systemic lupus erythematosus.
Smith CK; Kaplan MJ
Curr Opin Rheumatol; 2015 Sep; 27(5):448-53. PubMed ID: 26125102
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
Wang H; Li T; Chen S; Gu Y; Ye S
Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
[TBL] [Abstract][Full Text] [Related]
17. Type I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosis.
Thacker SG; Zhao W; Smith CK; Luo W; Wang H; Vivekanandan-Giri A; Rabquer BJ; Koch AE; Pennathur S; Davidson A; Eitzman DT; Kaplan MJ
Arthritis Rheum; 2012 Sep; 64(9):2975-85. PubMed ID: 22549550
[TBL] [Abstract][Full Text] [Related]
18. Peptidylarginine Deiminase Inhibition Prevents Diabetes Development in NOD Mice.
Sodré FMC; Bissenova S; Bruggeman Y; Tilvawala R; Cook DP; Berthault C; Mondal S; Callebaut A; You S; Scharfmann R; Mallone R; Thompson PR; Mathieu C; Buitinga M; Overbergh L
Diabetes; 2021 Feb; 70(2):516-528. PubMed ID: 33203696
[TBL] [Abstract][Full Text] [Related]
19. Dispensability of APRIL to the development of systemic lupus erythematosus in NZM 2328 mice.
Jacob CO; Guo S; Jacob N; Pawar RD; Putterman C; Quinn WJ; Cancro MP; Migone TS; Stohl W
Arthritis Rheum; 2012 May; 64(5):1610-9. PubMed ID: 22127792
[TBL] [Abstract][Full Text] [Related]
20. Peptidylarginine deiminase inhibition impairs Toll-like receptor agonist-induced functional maturation of dendritic cells, resulting in the loss of T cell-proliferative capacity: a partial mechanism with therapeutic potential in inflammatory settings.
Jang B; Kim HW; Kim JS; Kim WS; Lee BR; Kim S; Kim H; Han SJ; Ha SJ; Shin SJ
J Leukoc Biol; 2015 Feb; 97(2):351-62. PubMed ID: 25420918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
